User profiles for Peter B. Gilbert
 | Peter B. GilbertMember, Fred Hutchinson Cancer Research Center, and Research Professor, Department … Verified email at scharp.org Cited by 43904 |
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
In the coronavirus efficacy (COVE) phase 3 clinical trial, vaccine recipients were assessed
for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as …
for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as …
Immune-correlates analysis of an HIV-1 vaccine efficacy trial
BF Haynes, PB Gilbert, MJ McElrath… - … England Journal of …, 2012 - Mass Medical Soc
Background In the RV144 trial, the estimated efficacy of a vaccine regimen against human
immunodeficiency virus type 1 (HIV-1) was 31.2%. We performed a case–control analysis to …
immunodeficiency virus type 1 (HIV-1) was 31.2%. We performed a case–control analysis to …
[HTML][HTML] Evidence for antibody as a protective correlate for COVID-19 vaccines
A correlate of protection (CoP) is urgently needed to expedite development of additional
COVID-19 vaccines to meet unprecedented global demand. To assess whether antibody titers …
COVID-19 vaccines to meet unprecedented global demand. To assess whether antibody titers …
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
…, A Duerr, DW Fitzgerald, R Mogg, D Li, PB Gilbert… - The Lancet, 2008 - thelancet.com
Background Observational data and non-human primate challenge studies suggest that cell-mediated
immune responses might provide control of HIV replication. The Step Study …
immune responses might provide control of HIV replication. The Step Study …
[HTML][HTML] Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine
…, MJ McElrath, L Corey, PB Gilbert - … England Journal of …, 2013 - Mass Medical Soc
Background A safe and effective vaccine for the prevention of human immunodeficiency
virus type 1 (HIV-1) infection is a global priority. We tested the efficacy of a DNA prime–…
virus type 1 (HIV-1) infection is a global priority. We tested the efficacy of a DNA prime–…
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies
…, VR Polonis, FE McCutchan, PB Gilbert… - Journal of …, 2010 - Am Soc Microbiol
The restricted neutralization breadth of vaccine-elicited antibodies is a major limitation of
current human immunodeficiency virus-1 (HIV-1) candidate vaccines. In order to permit the …
current human immunodeficiency virus-1 (HIV-1) candidate vaccines. In order to permit the …
[HTML][HTML] A Covid-19 milestone attained—a correlate of protection for vaccines
… Panel B shows histograms (relative frequencies) of neutralizing antibody titers in these
trials. … In the phase 3 correlates analyses, investigators studied the titer of neutralizing …
trials. … In the phase 3 correlates analyses, investigators studied the titer of neutralizing …
Effect of dengue serostatus on dengue vaccine safety and efficacy
…, J Chen, SP Ng, PB Gilbert… - … England Journal of …, 2018 - Mass Medical Soc
Background In efficacy trials of a tetravalent dengue vaccine (CYD-TDV), excess hospitalizations
for dengue were observed among vaccine recipients 2 to 5 years of age. Precise risk …
for dengue were observed among vaccine recipients 2 to 5 years of age. Precise risk …
[HTML][HTML] Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition
L Corey, PB Gilbert, M Juraska… - … England Journal of …, 2021 - Mass Medical Soc
Background Whether a broadly neutralizing antibody (bnAb) can be used to prevent human
immunodeficiency virus type 1 (HIV-1) acquisition is unclear. Methods We enrolled at-risk …
immunodeficiency virus type 1 (HIV-1) acquisition is unclear. Methods We enrolled at-risk …
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in …
…, C Wester, SJ Heymann, PB Gilbert, L Stevens, T Peter… - Jama, 2006 - jamanetwork.com
ContextPostnatal transmission of human immunodeficiency virus-1 (HIV) via breastfeeding
reverses gains achieved by perinatal antiretroviral interventions.ObjectiveTo compare the …
reverses gains achieved by perinatal antiretroviral interventions.ObjectiveTo compare the …
